The clinical heterogeneity of late-onset MELAS

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The clinical heterogeneity of late-onset MELAS

We read with interest the response by Finsterer and Zarrouk-Mahjoub [1] to our manuscript ‘Case Report: 5 Year Follow-up of Adult Late-Onset Mitochondrial Encephalomyopathy with Lactic Acid and Stroke-Like Episodes (MELAS)’ [2–4]. We have the following responses: Regarding the doses of initial anti-epileptic medication (AEDs), since this was some time ago and at a different institution we do no...

متن کامل

A case of late-onset MELAS.

We describe a 60-year-old man with MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes) and discuss the mitochondrial DNA point mutation 3243. A diagnosis of MELAS should be considered in the appropriate clinical setting at any age.

متن کامل

Phenotypic heterogeneity of MELAS☆☆☆

With interest we read the article by Dvorakova et al. about 50 Czech patients carrying the m.3243ANG mutation [1]. It raises questions and concerns. Since MELAS is a progressive disease, we should be informed about the long-term follow-up findings in the 50 mutation carriers. How many of the 17 patients without clinical manifestations at inclusion developed MELAS during follow-up? How many of t...

متن کامل

Highlighting intrafamilial clinical heterogeneity in late-onset Pompe disease☆

BACKGROUND/AIMS Pompe disease is a rare metabolic disorder caused by deficiency of the lysosomal enzyme acid alpha-glycosidase (GAA). The late onset form of the disease is characterized by muscle weakness and respiratory involvement of variable severity. The aim of this short communication is to highlight the clinical variability of Pompe disease within siblings suffering from the disease. CA...

متن کامل

Low blood heteroplasmy-rate may cause late-onset MELAS☆☆☆★

Letter to the Editor The interesting article by Sunde et al. about a 54 yo female with MELAS due to the m.3243ANG mutation with a blood heteroplasmyrate of 31% and manifesting with recurrent stroke-like episodes(SLEs), tonic-clonic seizures, migraine, hypothyroidism, short stature, fatigability, and hearing-loss [1] raises the following comments and concerns. For epilepsy the patient was initia...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Molecular Genetics and Metabolism Reports

سال: 2017

ISSN: 2214-4269

DOI: 10.1016/j.ymgmr.2017.04.003